OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
Antonio Torrelo, Barbara Rewerska, María Laura Galimberti, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 1, pp. 23-32
Open Access | Times Cited: 44
Antonio Torrelo, Barbara Rewerska, María Laura Galimberti, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 1, pp. 23-32
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases
Jenne P. Ingrassia, Muhammad Haisum Maqsood, Joel M. Gelfand, et al.
JAMA Dermatology (2023) Vol. 160, Iss. 1, pp. 28-28
Closed Access | Times Cited: 30
Jenne P. Ingrassia, Muhammad Haisum Maqsood, Joel M. Gelfand, et al.
JAMA Dermatology (2023) Vol. 160, Iss. 1, pp. 28-28
Closed Access | Times Cited: 30
Challenges and Future Trends in Atopic Dermatitis
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 27
Julius Garcia Gatmaitan, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11380-11380
Open Access | Times Cited: 27
Systemic Immunomodulatory Treatments for Atopic Dermatitis
Aaron M. Drucker, Megan Lam, David Prieto‐Merino, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 9, pp. 936-936
Closed Access | Times Cited: 12
Aaron M. Drucker, Megan Lam, David Prieto‐Merino, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 9, pp. 936-936
Closed Access | Times Cited: 12
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis
Stella Hartono, Sheena Chatrath, Ozge Nur Aktaş, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Stella Hartono, Sheena Chatrath, Ozge Nur Aktaş, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Biologics and small molecules: the re-evolution in the treatment of atopic dermatitis in children and adolescents. Current state of the art and future perspectives
Enza D’Auria, Cristiana Indolfi, Miriam Acunzo, et al.
Expert Review of Clinical Immunology (2025)
Closed Access | Times Cited: 1
Enza D’Auria, Cristiana Indolfi, Miriam Acunzo, et al.
Expert Review of Clinical Immunology (2025)
Closed Access | Times Cited: 1
Biologic and Small Molecule Therapy in Atopic Dermatitis
Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 6
Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 6
Modern Management Approaches for Alopecia Areata
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access
Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
Sihan Wang, Ziqian Xu, Xiaoxia Zhu, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access
Sihan Wang, Ziqian Xu, Xiaoxia Zhu, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access
Infections in Patients with Atopic Dermatitis and the Influence of Treatment
Maddalena Napolitano, Maria Esposito, Maria Concetta Fargnoli, et al.
American Journal of Clinical Dermatology (2025)
Open Access
Maddalena Napolitano, Maria Esposito, Maria Concetta Fargnoli, et al.
American Journal of Clinical Dermatology (2025)
Open Access
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Comparative efficacy of biologics and small molecule drugs in treating pediatric atopic dermatitis in patients aged 2–18 years: A 12–16 week network meta‐analysis of randomized controlled trials
Su‐Boon Yong, Berne Ting, Ikbal Andrian Malau, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Su‐Boon Yong, Berne Ting, Ikbal Andrian Malau, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Yan Zhang, Shaoying Yuan, Yixing Wu, et al.
Inflammopharmacology (2025)
Closed Access
Systemtherapie der AD
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis
Qun Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
Qun Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
Emerging treatments for dermatologic diseases in infants, children, and adolescents: a systematic review of clinical trials on biologics and small molecule inhibitors.
Alireza Jafarzadeh, Elham Behrangi, Mina Khosravi, et al.
PubMed (2025)
Closed Access
Alireza Jafarzadeh, Elham Behrangi, Mina Khosravi, et al.
PubMed (2025)
Closed Access
Evidence‐Based Recommendations for Managing Atopic Dermatitis in Pediatric Patients: A Systematic Review and Meta‐Analysis From the Pediatric Dermatology Special Interest Group of IADVL
Rahul Mahajan, Rashmi Sarkar, Maitreyee Panda, et al.
International Journal of Dermatology (2025)
Closed Access
Rahul Mahajan, Rashmi Sarkar, Maitreyee Panda, et al.
International Journal of Dermatology (2025)
Closed Access
Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis
Hyun Jin Yim, Tiffany Jean, Peck Y. Ong
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 5, pp. 289-301
Open Access | Times Cited: 3
Hyun Jin Yim, Tiffany Jean, Peck Y. Ong
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 5, pp. 289-301
Open Access | Times Cited: 3
Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis
Qianyu Chen, Lian Cui, Yifan Hu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22014-e22014
Open Access | Times Cited: 8
Qianyu Chen, Lian Cui, Yifan Hu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22014-e22014
Open Access | Times Cited: 8
Effectiveness and safety of systemic therapy for moderate-to-severe atopic dermatitis in children and adolescent patients: a systematic review
Yu Zheng, Rui-Lian Ding, Jin Bu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Yu Zheng, Rui-Lian Ding, Jin Bu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Switching from baricitinib to dupilumab as an advanced‐line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study
Ayelet Ollech, Eran Cohen‐Barak, Amir Horev, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 7
Closed Access | Times Cited: 2
Ayelet Ollech, Eran Cohen‐Barak, Amir Horev, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 7
Closed Access | Times Cited: 2
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years
Andreas Wollenberg, Masanori Ikeda, Chia‐Yu Chu, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Andreas Wollenberg, Masanori Ikeda, Chia‐Yu Chu, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward
Narendra Kumar Bagri, Christine Chew, Athimalaipet V Ramanan
Pediatric Drugs (2023) Vol. 25, Iss. 6, pp. 635-647
Closed Access | Times Cited: 6
Narendra Kumar Bagri, Christine Chew, Athimalaipet V Ramanan
Pediatric Drugs (2023) Vol. 25, Iss. 6, pp. 635-647
Closed Access | Times Cited: 6
Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis
Bailin Chen, Shan Huang, X.F. Dong, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Bailin Chen, Shan Huang, X.F. Dong, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Neutrophils in Atopic Dermatitis
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 1
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 1
Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets
Meng Sun, Ze Chen, Huijuan Ding, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
Meng Sun, Ze Chen, Huijuan Ding, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
